DCF — ST. MARY MEDICAL CENTER INC.
Enterprise Value: $254.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$254.3M
Enterprise Value
$66.8M
PV of Cash Flows
$187.5M
PV of Terminal Value
$302.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $328.8M | $33.0M | 10.0% | $12.9M | $11.7M |
| Year 2 | $338.6M | $37.3M | 11.0% | $15.8M | $13.0M |
| Year 3 | $348.8M | $41.9M | 12.0% | $18.9M | $14.2M |
| Year 4 | $359.3M | $45.0M | 13.0% | $20.8M | $14.2M |
| Year 5 | $370.0M | $47.3M | 13.0% | $22.1M | $13.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $254.3M. Terminal value accounts for 74% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$319.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.09523185944622022
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5